# SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

> **NCT02730468** · — · COMPLETED · sponsor: **Karius, Inc.** · enrollment: 350 (actual)

## Conditions studied

- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02730468
- **Lead sponsor:** Karius, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2017-09
- **Final completion:** 2017-10
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2017-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02730468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02730468, "SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02730468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*